Thank you for subscribing to our e-newsletter! You will receive two e-newsletters weekly — one for news, and another for social media content. Be sure to check in daily for new SMA-related content.
- US Patient Groups Give Thumbs-Up to Rule Against Surprise Billing July 27, 2021
- Crip Wealth and the Tapestry of Pride July 26, 2021
- Novartis Stopping Work on Branaplam as Oral SMA Therapy July 26, 2021
- Early Work Supports Apitegromab’s Safety as SMA Muscle Therapy July 23, 2021
- Inviting People to Sit at the Table of My Disabled Life July 22, 2021